Pre-mRNA missplicing as a cause of human disease.

Regulated alternative splice site selection emerges as one of the most important mechanisms to control the expression of genetic information in humans. It is therefore not surprising that a growing number of diseases are either associated with or caused by changes in alternative splicing. These diseases can be caused by mutation in regulatory sequences of the pre-mRNA or by changes in the concentration of trans-acting factors. The pathological expression of mRNA isoforms can be treated by transferring nucleic acids derivatives into cells that interfere with sequence elements on the pre-mRNA, which results in the desired splice site selection. Recently, a growing number of low molecular weight drugs have been discovered that influence splice site selection in vivo. These findings prove the principle that diseases caused by missplicing events could eventually be cured.

[1]  M. Garcia-Blanco,et al.  Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing , 2003, Nature Medicine.

[2]  K. Jellinger,et al.  The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2‐BETA1 changes in sporadic Alzheimer's disease , 2006, Journal of neurochemistry.

[3]  Y. Jong,et al.  Treatment of spinal muscular atrophy by sodium butyrate , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Dirk G Kieback,et al.  Expression of splicing factors in human ovarian cancer. , 2004, Oncology reports.

[5]  T. Klimkait,et al.  Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A. , 2004, Nucleic acids research.

[6]  Stefan Stamm,et al.  Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. , 2002, Human molecular genetics.

[7]  E G Jones,et al.  Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. Andresen,et al.  Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometry. , 2003, Pediatrics.

[9]  Y. Eto,et al.  Single exon mutation in arylsulfatase A gene has two effects: loss of enzyme activity and aberrant splicing , 1994, Human Genetics.

[10]  T. Suormala,et al.  cblE Type of homocystinuria due to methionine synthase reductase deficiency: Functional correction by minigene expression , 2005, Human mutation.

[11]  D. Rodriguez,et al.  Aberrant Splicing of Exon 6 in the Pyruvate Denydrogenase-Elα mRNA Linked to a Silent Mutation in a Large Family with Leigh's Encephalomyelopathy , 1994, Pediatric Research.

[12]  S. Cawley,et al.  Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. , 2004, Genome research.

[13]  H. Jumaa,et al.  Blastocyst formation is blocked in mouse embryos lacking the splicing factor SRp20 , 1999, Current Biology.

[14]  S. Brenner,et al.  Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Christopher J. Lee,et al.  Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. , 2003, Nucleic acids research.

[16]  Bosiljka Tasic,et al.  Alternative pre-mRNA splicing and proteome expansion in metazoans , 2002, Nature.

[17]  C. Ware,et al.  ΔBAFF, an Alternate Splice Isoform That Regulates Receptor Binding and Biopresentation of the B Cell Survival Cytokine, BAFF* , 2003, Journal of Biological Chemistry.

[18]  G. Schellenberg,et al.  A distinct familial presenile dementia with a novel missense mutation in the tau gene. , 1999, Neuroreport.

[19]  P. Stenson,et al.  Human Gene Mutation Database (HGMD®): 2003 update , 2003, Human mutation.

[20]  G. Prendergast,et al.  Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma , 2000, International journal of cancer.

[21]  F. Muntoni,et al.  Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R Kole,et al.  Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Androphy,et al.  The regulation and regulatory activities of alternative splicing of the SMN gene. , 2004, Critical reviews in eukaryotic gene expression.

[24]  Index , 2000, Neuropharmacology.

[25]  S. Stamm,et al.  Function of Alternative Splicing , 2004 .

[26]  B. Kerem,et al.  Splicing regulation as a potential genetic modifier. , 2002, Trends in genetics : TIG.

[27]  T. Südhof,et al.  Neurexins: three genes and 1001 products. , 1998, Trends in genetics : TIG.

[28]  J. Castle,et al.  Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays , 2003, Science.

[29]  V. Beneš,et al.  Alternative Splicing Microarrays Reveal Functional Expression of Neuron-specific Regulators in Hodgkin Lymphoma Cells* , 2005, Journal of Biological Chemistry.

[30]  P. Fehlbaum,et al.  A microarray configuration to quantify expression levels and relative abundance of splice variants , 2005, Nucleic acids research.

[31]  B. Sullenger,et al.  Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Lin Jin,et al.  Aberrant RNA Processing in a Neurodegenerative Disease: the Cause for Absent EAAT2, a Glutamate Transporter, in Amyotrophic Lateral Sclerosis , 1998, Neuron.

[33]  C. Mann,et al.  Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Le code de l'épissage et sa modulation thérapeutique par des molécules chimiques , 2005 .

[35]  K. Nakai,et al.  Construction of a novel database containing aberrant splicing mutations of mammalian genes. , 1994, Gene.

[36]  D. Hunt,et al.  A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). , 2001, Molecular cell.

[37]  Thangavel Alphonse Thanaraj,et al.  ASD: the Alternative Splicing Database , 2004, Nucleic Acids Res..

[38]  K. Weinberg,et al.  Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. , 1995, Human molecular genetics.

[39]  A. Krainer,et al.  Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1 , 2002, Nature Genetics.

[40]  R. Carstens,et al.  An Intronic Sequence Element Mediates Both Activation and Repression of Rat Fibroblast Growth Factor Receptor 2 Pre-mRNA Splicing , 1998, Molecular and Cellular Biology.

[41]  T. Giordano,et al.  RNA as a drug target: methods for biophysical characterization and screening. , 2000, Trends in biotechnology.

[42]  C. Duijn,et al.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. , 1999, American journal of human genetics.

[43]  U. Francke,et al.  Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome , 1997, Nature Genetics.

[44]  Y. Hofmann,et al.  Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. , 2003, Human molecular genetics.

[45]  S Rosenberg,et al.  Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. , 2001, Cancer research.

[46]  Massimo Marconi,et al.  Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Y. Seyama,et al.  Silent nucleotide substitution in the sterol 27-hydroxylase gene (CYP 27) leads to alternative pre-mRNA splicing by activating a cryptic 5' splice site at the mutant codon in cerebrotendinous xanthomatosis patients. , 1998, Biochemistry.

[48]  S. Fisher,et al.  Dissection of epistasis in oligogenic Bardet–Biedl syndrome , 2006, Nature.

[49]  E. Makarov,et al.  RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing. , 2000, Human molecular genetics.

[50]  B. Sullenger,et al.  Ribozyme-Mediated Repair of Sickle β-Globin mRNAs in Erythrocyte Precursors , 1998 .

[51]  P. Harrison,et al.  Acute intermittent porphyria caused by defective splicing of porphobilinogen deaminase RNA: a synonymous codon mutation at -22 bp from the 5' splice site causes skipping of exon 3. , 1996, Journal of medical genetics.

[52]  E. Buratti,et al.  Missense, Nonsense, and Neutral Mutations Define Juxtaposed Regulatory Elements of Splicing in Cystic Fibrosis Transmembrane Regulator Exon 9* , 2003, Journal of Biological Chemistry.

[53]  R. Kole,et al.  Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. , 2003, The Journal of clinical investigation.

[54]  H. Dietz,et al.  Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection. , 1996, The Journal of clinical investigation.

[55]  E. Androphy,et al.  An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy. , 2004, Biochemical and biophysical research communications.

[56]  M. Gabut,et al.  Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Valcárcel,et al.  Alternative pre-mRNA splicing: the logic of combinatorial control. , 2000, Trends in biochemical sciences.

[58]  Michael Ruogu Zhang,et al.  An alternative-exon database and its statistical analysis. , 2000, DNA and cell biology.

[59]  E. Rassart,et al.  Gris1, a New Common Integration Site in Graffi Murine Leukemia Virus-Induced Leukemias: Overexpression of a Truncated Cyclin D2 due to Alternative Splicing , 2003, Journal of Virology.

[60]  S. Stamm,et al.  Ischemia Induces a Translocation of the Splicing Factor tra2-β1 and Changes Alternative Splicing Patterns in the Brain , 2002, The Journal of Neuroscience.

[61]  D. Geschwind,et al.  Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Brenton R Graveley,et al.  Exon-specific RNAi: a tool for dissecting the functional relevance of alternative splicing. , 2002, RNA.

[63]  G. Perdew,et al.  Regulation of Gene Expression , 2008, Goodman's Medical Cell Biology.

[64]  B. Graveley,et al.  Alternative splicing of the Drosophila Dscam pre-mRNA is both temporally and spatially regulated. , 2001, Genetics.

[65]  L. Castagnetta,et al.  Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. , 1993, Cancer research.

[66]  Teresa Casals,et al.  New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12. , 2003, Human molecular genetics.

[67]  S Ferrai,et al.  Mutation of CD40 gene cause a novel autosomal recessive form of hyper IgM , 2001 .

[68]  D. Black.  Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.

[69]  Xiang-Dong Fu,et al.  ASF/SF2-Regulated CaMKIIδ Alternative Splicing Temporally Reprograms Excitation-Contraction Coupling in Cardiac Muscle , 2005, Cell.

[70]  R J Wyatt,et al.  Elevated concentration of N-CAM VASE isoforms in schizophrenia. , 2000, Journal of psychiatric research.

[71]  G. Schellenberg,et al.  Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[72]  David Glick,et al.  Defects in pre-mRNA processing as causes of and predisposition to diseases. , 2002, DNA and cell biology.

[73]  R. Kole,et al.  Antisense derivatives of U7 and other small nuclear RNAs as tools to modify pre-mRNA splicing patterns , 2004 .

[74]  Z. Hall.  Cancer , 1906, The Hospital.

[75]  C. Junien,et al.  WT1 splicing alterations in Wilms' tumors. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[76]  Jinhua Wang,et al.  ESEfinder: a web resource to identify exonic splicing enhancers , 2003, Nucleic Acids Res..

[77]  B. Poll-The,et al.  Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship , 2004, Human Genetics.

[78]  Robert B Darnell,et al.  Nova-1 Regulates Neuron-Specific Alternative Splicing and Is Essential for Neuronal Viability , 2000, Neuron.

[79]  B. Stockwell,et al.  Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism. , 2004, Chemistry & biology.

[80]  N. Gray,et al.  A novel role for shuttling SR proteins in mRNA translation. , 2004, Genes & development.

[81]  E. Androphy,et al.  Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. , 2001, Human molecular genetics.

[82]  J. Manley,et al.  A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy , 2003, Nature Genetics.

[83]  H. Ushijima,et al.  ATP7A gene mutations in 16 patients with Menkes disease and a patient with occipital horn syndrome. , 2001, American journal of medical genetics.

[84]  P. Stenson,et al.  Human Gene Mutation Database (HGMD , 2003 .

[85]  M. Garcia-Blanco,et al.  Alternative splicing in disease and therapy , 2004, Nature Biotechnology.

[86]  T. Maniatis,et al.  An extensive network of coupling among gene expression machines , 2002, Nature.

[87]  A. Krainer,et al.  Correction of disease-associated exon skipping by synthetic exon-specific activators , 2003, Nature Structural Biology.

[88]  Molly M. Huntsman,et al.  Altered ratios of alternatively spliced long and short γ2 subunit mRNAs of the γ-amino butyrate type A receptor in prefrontal cortex of schizophrenics , 1998 .

[89]  E. Androphy,et al.  In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes. , 2004, RNA.

[90]  J. Královičová,et al.  Branch site haplotypes that control alternative splicing. , 2004, Human molecular genetics.

[91]  T. Suormala,et al.  CblE type of homocystinuria due to methionine synthase reductase deficiency: Clinical and molecular studies and prenatal diagnosis in two families , 2002, Journal of Inherited Metabolic Disease.

[92]  A. Hartmann,et al.  The intranuclear localization and function of YT521-B is regulated by tyrosine phosphorylation. , 2004, Human molecular genetics.

[93]  B. Sullenger,et al.  Functional repair of a mutant chloride channel using a trans-splicing ribozyme. , 2002, The Journal of clinical investigation.

[94]  M. Ittmann,et al.  Alternative splicing of fibroblast growth factor receptors in human prostate cancer , 2001, The Prostate.

[95]  S. Haas,et al.  Strengths and weaknesses of EST-based prediction of tissue-specific alternative splicing , 2004, BMC Genomics.

[96]  [Selective modification of alternative splicing by indole derivatives that target SR protein splicing factors]. , 2005, Medecine sciences : M/S.

[97]  B. Sullenger,et al.  Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors. , 1998, Science.

[98]  S. Stamm,et al.  Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[99]  Xiangdong Xu,et al.  SC35 plays a role in T cell development and alternative splicing of CD45. , 2001, Molecular cell.

[100]  K. Arima,et al.  Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies , 2004, Neuroscience Letters.

[101]  E. Aronica,et al.  Increased Expression of Neuronal Nitric Oxide Synthase Spliced Variants in Reactive Astrocytes of Amyotrophic Lateral Sclerosis Human Spinal Cord , 2001, The Journal of Neuroscience.

[102]  Hagai Bergman,et al.  Identifying subtle interrelated changes in functional gene categories using continuous measures of gene expression , 2005, Bioinform..

[103]  Y. Nie,et al.  Intracellular Localization of Differentially Regulated RNA-specific Adenosine Deaminase Isoforms in Inflammation* , 2003, Journal of Biological Chemistry.

[104]  R. Guigó,et al.  Are splicing mutations the most frequent cause of hereditary disease? , 2005, FEBS letters.

[105]  Stephen N. Jones,et al.  An Alternative Splice Form of Mdm2 Induces p53-independent Cell Growth and Tumorigenesis* , 2004, Journal of Biological Chemistry.

[106]  M. Hims,et al.  Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. , 2003, Human molecular genetics.

[107]  T. Cooper,et al.  Pre-mRNA splicing and human disease. , 2003, Genes & development.

[108]  C. Largman,et al.  Alternative splicing of the HOX 2.2 homeobox gene in human hematopoietic cells and murine embryonic and adult tissues. , 1991, Nucleic acids research.

[109]  J. Qiu,et al.  EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia. , 2003, Biochemical and biophysical research communications.

[110]  C. Lorson,et al.  An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA , 2001, Gene Therapy.

[111]  A. Harris,et al.  Analysis of mutations and alternative splicing patterns in the CFTR gene using mRNA derived from nasal epithelial cells. , 1994, Human Molecular Genetics.